2017 has brought many changes, one most notably being the new Administration and its impact on the future of American healthcare. For 340B program participants there are many unanswered questions about what healthcare reform will mean for this vital drug pricing program.
Reform of the Affordable Care Act (ACA, Obamacare) may affect the 340B program in some way, but this is not the only concern, as members of Congress and other government officials see the program as a cause of high drug prices in the United States. In order for our legislators to fight for the longevity of the 340B program, they need to hear from those it impacts most: safety net providers. Please consider reaching out to your congressional representative in support of the 340B program. Visit www.govtrack.us/congress/members for your congressional representative’s contact information.